250+ investors that invest in your industry and stage
Get 250+ investors tailored to your startup
  • Invest in your industry and stage
  • Emails & contact info included
  • Excel and CSV export
  • Automatically
Trusted by 3,000+ startups

Top 50 Medical Startup Investors in China in September 2025

A list of 50 angel investors and VC (Venture Capital) funds that invest in Medical startups based in China. We rank investors based on the number of investments they made in Medical companies from China. We update this investor list every month.

Top 50 Medical Startup Investors in China in September 2025

Investor Medical China investments
HSG 34
BioVenture 33
Qiming Venture Partners 27
Med-Fine Capital 25
Legend Capital 23
Frees Fund 20
Cowin Venture 18
Shanghai Biomedical Industrial Equity Investment Fund 17
Lilly Asia Ventures 17
Marathon Venture Partners 17
Puhua Capital 17
Matrix Partners China 16
IDG Capital 16
Prox Ventures 16
Share Capital 15
Northern Light Venture Capital 15
ZSVC 15
Legend Star 15
Jan Hammer 14
Cowin Capital 14
CDH Investments 13
Highlight Capital 13
Dalton Venture 13
Sherpa Healthcare Partners 12
Goldport Capital 12
BioTrack Capital 12
Taiyu Investment 11
Lenovo Capital and Incubator Group (LCIG) 11
Shenzhen Capital Group 10
Cenova 10
CD Capital 9
Hillhouse Investment 9
Oriza Seed Capital (Oriza Yuandian) 9
Huagai Capital 9
Kaitai Capital 9
Long Hill Capital 9
Gaorong Capital 9
Trustbridge Partners 9
Sunland Fund 9
BIOCHING CAPITAL 8
LYFE Capital 8
Tiantu Capital 8
Pan-Lin Capital 8
Taiyu Investment 8
Haibang Capital 8
Sunz Fund 8
Insight Capital 8
Oriental Fortune Capital 8
Co-Stone Venture Capital 8
Shunwei Capital 8
Find investors that fund startups like yours. Automatically.
Our algorithm will find investors that invest in your industry, stage, and geography.
Investor list
HSG VC Fund · Beijing, Beijing, China · 34 investments in the past 12 months
We help founders build enduring companies.
Show more
Investment focus
  • Health Care, Biotechnology, Artificial Intelligence
  • Series A, Series B, Series C
  • China, United States, Hong Kong
Portfolio highlights
  • MarqVision — Effortlessly discover and remove counterfeits to protect your sales and reputation.
  • Midas — Midas is the first neobroker of Turkey, providing zero commission Turkish and American stocks.
  • Yunzhou Zhiwei — Yunzhou Zhiwei is a high-tech startup focused on serving large-scale equipment maintenance industries such as aviation, aerospace, shipbuilding, and rail transit. It leverages smart maintenance concepts and advanced digital technologies to make complex equipment maintenance more efficient and lean. The company drives industrial transformationtoward intelligent maintenance, helping enterprises enhance growth, efficiency, and operational excellence.
BioVenture VC Fund · Suzhou, Jiangsu, China · 15 investments in the past 12 months
Suzhou Industrial Park Bioventure Investment Management Limited (Bioventure) was established in September 2013. Bioventure its first element of the new bio-industry funds 540 million yuan fund size. Bioventure specialize in the field of life sciences in the early stages of the venture capital investments as having high strength and growth, greaterdevelopment space, excellent management team, biotechnology, drug discovery, medical devices and healthcare services companies, and provide capital, management , operation and other aspects of post-investment support and services.Bioventure brought together senior investment professionals team with bio-pharmaceutical industry investment experience, strong fund management, entrepreneurship and venture capital and operating experience in business, have a deep understanding of the domestic and foreign markets, capable of its forward-looking international perspective and extensive The industry has the potential resources to help innovative companies grow rapidly and gain greater success, while giving fund investors bring considerable returns.Suzhou Industrial Park, the core investor BioBay has the country's best medical and pharmaceutical incubator function, use the platform, the project team has great resources and industrial service advantages, Yuan-sheng venture has successfully invested in 20 projects have been cast projects in their own development and follow-up financing, has made outstanding achievements in the industry for all to see, and won the Venture's trust and praise.By focusing and extensive industry resources, Bioventure determined to become one of China's most successful medical and pharmaceutical venture fund. Bioventure expectations and in the medical and pharmaceutical industry where there joint venture development cooperation.
Show more
Investment focus
  • Health Care, Medical, Biotechnology
  • Series A, Series B, Seed
  • China, United States, Taiwan
Portfolio highlights
  • Libo Biotech — Libo Biotech is a cutting-edge biotechnology company dedicated to the discovery and development of innovative small molecule therapeutics that specifically target RNA.
  • Yanshengchao — Room A204-1, Floor 2, Building 2, Yard 9, Yike Road Life Science Park, Changping District Beijing China
  • Hongxin Biology — Hongxin Bio is an mRNA drug developer, focusing on nucleic acid drug delivery and RNA drug development.
Qiming Venture Partners VC Fund · Shanghai, Shanghai, China · 49 investments in the past 12 months
Founded in 2006, Qiming Venture Partners is a leading China venture capital firm with offices in Shanghai, Beijing, Suzhou, Hong Kong in China, and Singapore.Currently, Qiming Venture Partners manages eleven US Dollar funds and seven RMB funds with $9.5 billion in capital raised. Since our establishment, we have invested in outstanding companiesin the Technology and Consumer (T&C) and Healthcare industries at the early and growth stages.Since our debut, we have backed over 530 fast-growing and innovative companies. Over 200 of our portfolio companies have achieved exits through IPOs at the NYSE, NASDAQ, HKEX, Shanghai Stock Exchange, or Shenzhen Stock Exchange, or through M&A or other means. There are also over 70 portfolio companies that have achieved unicorn or super unicorn status.
Show more
Investment focus
  • Health Care, Biotechnology, Medical
  • Series B, Series A, Series C
  • China, United States, Hong Kong
Portfolio highlights
  • Yanshengchao — Room A204-1, Floor 2, Building 2, Yard 9, Yike Road Life Science Park, Changping District Beijing China
  • Minghui Pharmaceutical — Minghui Pharmaceutical is a biopharmaceutical business that specializes in immunology and oncology medicines for unmet needs.
  • Huimei Technology — Huimei Technology is a National high-tech enterprise that offers medical artificial intelligence solutions.
Med-Fine Capital VC Fund · Shanghai, Shanghai, China · 5 investments in the past 12 months
Med-Fine Capital is a venture capital firm focusing on early stage investments in China healthcare industry. The company is headquartered in Shanghai with offices in Beijing and Shenzhen.
Show more
Investment focus
  • Health Care, Medical, Biotechnology
  • Series A, Seed, Series B
  • China, United States
Portfolio highlights
  • BV Laser — BV Laser is a manufacturer of medical beauty equipment.
  • Allink Biotherapeutics — Allink Biotherapeutics is a biopharmaceutical company that focuses on oncology and immunological treatment.
  • Excalipoint Therapetics — Excalipoint Therapeutics is a Private limited company.
Legend Capital VC Fund · Beijing, Beijing, China · 27 investments in the past 12 months
Legend Capital, a subsidiary of Legend Holdings Ltd., started its vintage year in April, 2001 with a mission to become a top-notch and the most respected venture capital investment manager in China.Managing up to US$700 million across four funds, Legend Capital focuses on driving high-growth ventures with operations substantially based in Chinaor on markets related to China.Legend Capital mainly invests in early stage IT companies, specifically, in sectors of network applications and services, outsourcing and professional services, Infrastructure (IC design/key components), and mid-market growth stage companies in the fields of consumer goods, clean technology, health care, equipment manufacturing and modern services.Among over 60 portfolio companies are Joyo.com (acquired by Amazon.com), SinoCom (0299.HK), Solarfun Power (Nasdaq: SOLF), Spreadtrum Communications (Nasdaq: SPRD), China Sunshine Paper (2002.HK), and VanceInfo (NYSE:VIT), Eyang (0117.HK), etc.As an active investor, Legend Capital provides its portfolio companies extensive business resources and tailored services to assist with business development, company image building, and other critical company building activities on Chinese market so as to add value and maximize returns. Legend Capital is proud and thankful that it has the opportunity to blaze a trail with its innovative practice for China's venture capital industry.
Show more
Investment focus
  • Health Care, Medical, Biotechnology
  • Series B, Series A, Series C
  • China, United States, South Korea
Portfolio highlights
  • Obita — Obita is a B2B financial network that offers stablecoin-driven transactions for enterprises, merchants, and fintechs.
  • Elf Life — Elf Life is a medical device developer specializing in the design, development, and production of innovative healthcare technologies aimed at improving patient outcomes and enhancing the quality of medical care.
  • X Square — X Square is a company focused on developing universal embodied large models for robots, aiming to create a universal brain-cerebellum system that offers comprehensive capabilities from perception to action.
Frees Fund VC Fund · Beijing, Beijing, China · 13 investments in the past 12 months
By adopting revolutionary mechanisms, FREES FUND is devoted to change the long-established rules in the venture capital. By leveraging the cutting-edge technologies and resources, FREES FUND aims at investing in great startups and helping them grow into great enterprises that are valuable to our society. We mainly invest in early-stagestartups, and hope to become their first-round institutional investor. Our primary interested areas are broad-sense TMT (Technology, Media, Telecom), B2B and deep technology.
Show more
Investment focus
  • Artificial Intelligence, Medical, Biotechnology
  • Series A, Seed, Angel
  • China, United States, Singapore
Portfolio highlights
  • Boin Biotechnology — Boin Biotechnology is a cutting-edge biopharmaceutical company. The company is dedicated to the development of gene therapy drugs, with a particular focus on advancing the next generation of gene therapy.
  • Interstellar Lightyear — Interstellar Lightyear Technology is a developer specializing in dexterous robotic hands, focusing on creating intelligent dexterous hands with advanced capabilities for precise manipulation.
  • Dingou Biopharmaceuticals — Dingou Biotechnology is a developer of allergen diagnosis and treatment products, mainly engaged in allergen-specific diagnosis and treatment business
Cowin Venture VC Fund · Beijing, Beijing, China · 5 investments in the past 12 months
Founded in 2009, Cowin Venture is an angel and early-stage investor in TMT and Healthcare. We keep nurturing growth-stage companies graduated from their angel investment portfolio. Cowin’s business network covers China and USA. They have offices in Suzhou, Nanjing, Shanghai, Beijing and Hong Kong.
Show more
Investment focus
  • Health Care, Biotechnology, Medical
  • Series A, Angel, Series B
  • China, United States, Canada
Portfolio highlights
  • Fine Vision — Fine Vision is a company with R&D facilities in Nanjing and Wuhan that focuses on femtosecond laser application research in the fields of ocular surgery and biomaterial processing. The entire femtosecond laser corneal refractive surgery equipment, its first commercially available item, was developed by the university's WuhanOptoelectronics National Research Center under the Huazhong Technology Technology transition.
  • Guanchen Biotechnology — Guanchen Biotechnology is a developer of innovative cosmetic ingredients.
  • Excalipoint Therapetics — Excalipoint Therapeutics is a Private limited company.
Shanghai Biomedical Industrial Equity Investment Fund VC Fund · Huangpu, Shanghai, China · 7 investments in the past 12 months
Shanghai Biomedical Industrial Equity focuses on areas that are in line with the development strategy of the biomedical industry.
Show more
Investment focus
  • Health Care, Medical, Biotechnology
  • Series A, Series B, Seed
  • China, United States, Hong Kong
Portfolio highlights
  • Editact — Editact specializes in the development of novel gene treatments for Alzheimer's disease. It focuses on unmet clinical requirements in familial Alzheimer's disease (FAD) and is developing "one-to-many" gene editing therapeutics.
  • Easy Flow — Easy-Flow is committed to efficiently creating a complete set of solutions in the field of peripheral interventional devices.
  • NeuShen Therapeutics — NeuShen Therapeutics is a biotechnology company trailblazing the future treatment of neurological and psychiatric disorders.
Lilly Asia Ventures VC Fund · Shanghai, Shanghai, China · 13 investments in the past 12 months
Lilly Asia Ventures (LAV) is a leading biomedical venture capital firm headquartered in China, with offices in Shanghai, Hong Kong, and Palo Alto.
Show more
Investment focus
  • Biotechnology, Health Care, Medical
  • Series A, Series B, Series C
  • China, United States, Hong Kong
Portfolio highlights
  • Enchannel — Enchannel Medical is a global innovation platform that focuses on electrophysiology and provides atrial fibrillation treatment solution around "3D mapping + PFA ablation".
  • Kriya Therapeutics — Kriya is a biopharmaceutical company developing gene therapy to address common diseases that impact millions of people worldwide. Learn more.
  • Heyuan Medical Devices — Heyuan Medical Devices serves as an enterprise service provider, offering specialized medical equipment and support solutions tailored to the needs of healthcare institutions and organizations
Marathon Venture Partners VC Fund · Shanghai, Shanghai, China
Marathon Venture Partners is an international VC fund that focuses on early and growth stage companies in healthcare and Fintech industry.
Show more
Investment focus
  • Health Care, Medical, Biotechnology
  • Series A, Series B, Angel
  • China, United States, Hong Kong
Portfolio highlights
  • Natus — Nators specializes in precision motion positioning platforms, mechanical sensors, and nanoscience instruments, the company has developed precision positioning and sensing products for various applications, including optics, microscopy, and nano-level characterization and analysis. With a strong R&D capability and a complete production capacity,the company has become a partner of many domestic laboratories.
  • Kangai Medical — Kangai Medical specialises on clinical nutrition and rehabilitation
  • Femtosecond Technology — Femtosecond Technology is a developer of label-free biological imaging technology.Femtosecond Technology is a high-tech, "specialized and innovative" firm focusing on the application of femtosecond laser technology in clinical diagnosis and treatment, as well as biomedical industrialization.
Puhua Capital VC Fund · Hangzhou, Zhejiang, China · 16 investments in the past 12 months
Puhua Capital is an equity investment firm that focuses on early and middle project. Puhua Capital provides the required resources and management experience for the invested enterprise, investing funds and more resources and wisdom. Puhua Capital has invested nearly 300 excellent start-ups.
Show more
Investment focus
  • Health Care, Medical, Manufacturing
  • Series A, Series B, Seed
  • China, United Kingdom, United States
Portfolio highlights
  • Kangweijian Bio — Kangweijian Bio is a health food manufacturer and distributor dedicated to delivering safe, high-quality products and services across global markets, specializing in food and cosmetic raw materials, health food ingredients, pharmaceutical excipients, and animal nutrition.
  • LuMing Robotics — LuMing Robotics is a developer of intelligent robots. LuMing Robotics focuses on the field of embodied intelligent robots, and its business covers intelligent robot R&D and sales, artificial intelligence algorithm development, etc.
  • Rongrui Technology — Rongrui Technology is an industrial enzyme developer, involved in industrial enzyme research and development; technical services, technology development, technology consulting, technology exchange, technology transfer, and technology promotion.
Matrix Partners China VC Fund · Beijing, Beijing, China · 11 investments in the past 12 months
Matrix Partners China builds long-term relationships with entrepreneurs and helps them build significant, industry-leading companies.Since its inception in 1977, Matrix Partners China has made hundreds of investments and played an active role in the development of many successful businesses, 50 of which went on to IPO, and 75 of which have goneon to profitable M&A events. The firm consistently ranks in the top venture firms in terms of returns to its investors.Matrix Partners China combines local knowledge with global experience and vision. Its team consists of both former entrepreneurs and experienced investors. Its past successes include Focus Media, Eachnet, and Baidu, among others. The company invests across multiple sectors and stages.
Show more
Investment focus
  • Health Care, Biotechnology, Software
  • Series A, Series B, Series C
  • China, United States, Hong Kong
Portfolio highlights
  • Sand.ai — Sand AI is an AI company that focuses on producing videos.
  • TOYA — TOYA specializes in the production of ultra-fine copper and copper alloy conductors.
  • Stablestocks Lab — Stablestocks Lab focuses on the on-chain stock ecosystem, aiming to bridge trillions of equity liquidity into DeFi.
IDG Capital VC Fund · Beijing, Beijing, China · 23 investments in the past 12 months
IDG Capital is an investment firm that funds early- to growth-stage companies in the technology sector. Today they work with private equity and venture capital fund managers, investment advisors, and business entities from around the world. Their limited partners include many internationally reputable investors, including sovereign wealth funds,pension funds, institutional investors, major charities, university endowments, family offices, and business luminaries.IDG Capital brings a powerful combination of global perspective and local experience to investment management. As long-term value investors, they are highly skilled at mobilizing global resources to address local needs, especially for Inbound and outbound opportunities in China and the rest of Asia. Their highly skilled team has an in-depth understanding of the Chinese market and enjoys close relationships with many influential business leaders.
Show more
Investment focus
  • Software, Internet, E-Commerce
  • Series A, Series B, Series C
  • China, United States, India
Portfolio highlights
  • Minova Pharma — Minova Pharma focuses on the development of novel medications in the spiritual and medicinal beauty domains.
  • Hongxin Biology — Hongxin Bio is an mRNA drug developer, focusing on nucleic acid drug delivery and RNA drug development.
  • Rongguang Optics — Rongguang Optics is a company specializing in optical instrument manufacturing, along with vacuum coating processing, industrial design services, and plastic product manufacturing.
Prox Ventures VC Fund · Shanghai, Shanghai, China
Proxima Ventures focuses in the healthcare industry, supporting outstanding enterprises with innovative technologies or service models that have tremendous potential.They manage multiple funds in RMB and US dollar, covering from seed to growth stages. Their team members with multidisciplinary backgrounds and resourceful networks, have many yearsof remarkable venture capital experience and achievements. They believe that active and effective collaboration with entrepreneurs will make substantial economic returns while bring meaningful improvements in public health.
Show more
Investment focus
  • Medical, Biotechnology, Health Care
  • Seed, Funding Round, Series A
  • China, United States, United Kingdom
Portfolio highlights
  • Rhino Medical — Rhino Medical develops advanced technologies with independent intellectual property rights. The founding team has rich experience in R&D, marketing, and clinical. On the basis of benchmarking imported phacoemulsification instruments and vitrectomy instruments
  • Tuanxiang Pharmaceutical — Tuanxiang Pharmaceutical is an innovative drug research and development company that combines traditional new drug research and development with the use of the world's leading unique phase separation technology.
  • Rapafusyn Pharmaceuticals — Rapafuysn is pioneering RapaGlues - a modality of non-degrading molecular glues that addresses hard-to-drug targets.
Share Capital VC Fund · Shenzhen, Guangdong, China
Share Capital is a venture capital firm specializing in seed, start-up, early, middle, growth capital, and Pre-IPO investments. it primarily invests in big living, medical healthcare, and internet innovation. In medical healthcare, it seeks to invests in pharmaceuticals, innovative equipment, biotechnology, diagnostic testing equipment andreagents, anti-infectives, drug discovery, medical health service, mobile medical services, and informatization.
Show more
Investment focus
  • Health Care, Medical, Biotechnology
  • Series A, Series B, Seed
  • China, United States, Colombia
Portfolio highlights
  • Depp CNC — Depp CNC is a research and development manufacturer of CNC machine tools and core accessories.
  • Microview — Microview is a high-tech enterprise specializing in the research and development of high-precision complex process chip packaging equipment.
  • Jodell Robotics — Jodell develops intelligent robotic equipment designed to serve in automotive and logistics industries.
Northern Light Venture Capital VC Fund · Beijing, Beijing, China · 7 investments in the past 12 months
Supporting the next generation of entpreneurs in enterprise, healthcare, and consumer with disruptive potential.
Show more
Investment focus
  • Health Care, Medical, Biotechnology
  • Series A, Series B, Seed
  • China, United States, South Korea
Portfolio highlights
  • iRegene — iRegene researches and develops pharmaceutical therapy for neurodegenerative and rare diseases.
  • Wala English — Wala English is a provider of comprehensive full-process AI contextual learning services, leveraging artificial intelligence to deliver personalized, immersive language learning experiences that adapt to each learner’s needs, context, and progress throughout their educational journey.
  • Hertz Life Science Technology — Hertz Life Science Technology uses virus-like particle VLPs technology to develop animal and human vaccines.The company has several underlying core patented technologies and has established a stable and efficient research and development platform based on the Jiyin Biomedical Transformation (Greater Bay Area) base, and actively promotes theresearch and development of vaccines.At present, the company has carried out extensive and in-depth cooperation with large enterprises such as Qingdao Yibang and Wen's Group, and its R&D strength has been highly recognized by peers and upstream and downstream enterprises.
ZSVC VC Fund · Beijing, Beijing, China · 5 investments in the past 12 months
ZSVC is a Chinese venture capital firm specialized in seed and early stage investments.
Show more
Investment focus
  • Manufacturing, Medical, Health Care
  • Series A, Seed, Series B
  • China, United States, India
Portfolio highlights
  • Micot — Micot is a new molecular entity drug developer for peptides, dedicated to the development of innovative drugs, multi- and protein-based innovative biopharmaceuticals, vaccines and biomolecular drug delivery systems and products, and for drug screening and biopharmaceutical research. The technology combines to provide users with Bio-Res-Deliv, abiological macromolecular respiratory drug delivery system, suitable for the treatment of cardiovascular diseases, metabolic diseases, liver diseases and the like.
  • Deruicore — Deruicore is an integrated research and development based manufacturing company.
  • Zhisheng Bio — Zhisheng Bio specialzies in product research and development, and market transformation of biopharmaceutical products.
Legend Star VC Fund · Beijing, Beijing, China · 7 investments in the past 12 months
Legend Star helps entrepreneurs create great businesses through investments, CEO training sessions and an entrepreneurs alliance.Since 2008, Legend Star has incubated and invested in nearly 600 companies and is deeply integrated in the Chinese entrepreneurial ecosystem.Legend Star is the independent early-stage investment arm of LegendHoldings. Legend Holdings is the parent company of Lenovo, Raycom Real Estate, Joyvio Agribusiness and a large range of fast-growing Chinese companies.
Show more
Investment focus
  • Health Care, Medical, Biotechnology
  • Series A, Seed, Angel
  • China, United States, France
Portfolio highlights
  • VelaVigo — VelaVigo is a start-up company engaged in macromolecular biopharmaceuticals.
  • Zhizai Wujie — Zhizai Wujie is a robotics company that specializes in research, development, and application of humanoid robots.
  • Direct Drive Technology — Direct Drive Technology provides direct drive solutions to replace the reduction gears in any machine. The company has a complete set of technologies for robot joints from sensors, drivers to motor bodies. Drive Tech uses a unique direct drive precise & powerful motion solution, thereby helping many other industries to boost different products.
Jan Hammer Angel · London, England, United Kingdom · 11 investments in the past 12 months
Jan Hammer is the partner at Index and the Board observer of Harmonic. Jan attended Oxford University.
Show more
Investment focus
  • Health Care, Medical, Medical Device
  • Series A, Series B, Seed
  • China, United States, United Kingdom
Portfolio highlights
  • MacroLux — MacroLux Medical Technology Co., Ltd.
  • Yuetong Eye Clinic — Yuetong Eye Clinic is a medical institution that provides myopia surgery for adults and myopia prevention and control for adolescents. It is a medical institution focusing on adult myopia surgery and adolescent myopia prevention and control.
  • Xiwei Biotechnology — Xiwei Biotechnology is an ophthalmology implanted medical device developer that specializes in the unique product development of new bio-modified materials for ocular implantable medical devices and regenerative medicine.
Cowin Capital VC Fund · Shenzhen, Guangdong, China · 35 investments in the past 12 months
Cowin Capital is a private placement equity investment company focusing on investing in a pioneering enterprise on a long-term basis. It has 18 years of experience in capital management, whose capital management scale was among the front rank, which invested more than 300 companies, of which 60 more became public companies, and 150 moresuccessfully exit.The company was successfully listed on NEEQ, with code 832793, as the third listed famous domestic venture capital institution in NEEQ. It is committed to supporting the growth of small and medium enterprises, continue to launch high-quality listed companies in China Capital Market.
Show more
Investment focus
  • Manufacturing, Health Care, Biotechnology
  • Series A, Series B, Seed
  • China, Hong Kong, United States
Portfolio highlights
  • Yiqi Future — Yiqi Future is a cutting-edge high-tech company dedicated to the research, development, and innovation of advanced AI-powered physical therapy robots. With a strong focus on integrating artificial intelligence, robotics, and biomedical engineering, the company aims to revolutionize the rehabilitation and healthcare industry by providingintelligent, efficient, and personalized therapeutic solutions.
  • Zhongzhi Xinying — Zhongzhi Xinying is a laser processing solution provider focused on developing and applying laser technology. Its products serve industries such as aerospace, rail transportation, shipbuilding, IT manufacturing, and medical.
  • Anno Robot (Shenzhen) Co. — RobotAnno (Shenzhen) Lmt. Co., established in April 2017, specializes in the development and manufacturing of desktop robotic arms. As a national high-tech enterprise, it focuses on research, production, sales, and service of robotic arms and commercial integrated solutions. The company's product lineup includes industrial robots, robot bubbletea and coffee vending machines, and robot bartender machines. Through continuous innovation, RobotAnno aims to provide sophisticated robotic solutions for various applications, enhancing efficiency and automation in different industries.
CDH Investments VC Fund · Kowloon City, Kowloon, Hong Kong · 21 investments in the past 12 months
CDH Investments is an international alternative asset fund manager with over $27 billion of assets under management. CDH Investments was established in 2002 by the former private equity group of China International Capital Corporation and is managed by an experienced team of senior private equity professionals who have worked together for manyyears focusing all their professional time on investing in China. CDH has consistently delivered superior returns relative to industry peers and is well positioned to continue to generate superior returns due to the team's proven investment experience and expertise investing in China.
Show more
Investment focus
  • Manufacturing, Health Care, Biotechnology
  • Series A, Series B, Series C
  • China, United States, Canada
Portfolio highlights
  • ZSPepLib — ZSPepLib is a peptide lead drug developer, established in January 2017, coordinates Zhuzhou, Hunan. It is a platform-based company specializing in peptide lead drug discovery, focusing on the development, production, sales and new peptide drugs of the large-capacity peptide library. Screening R&D technical services.
  • Kangweijian Bio — Kangweijian Bio is a health food manufacturer and distributor dedicated to delivering safe, high-quality products and services across global markets, specializing in food and cosmetic raw materials, health food ingredients, pharmaceutical excipients, and animal nutrition.
  • Yizheng Biology — Yi Zheng Bio is a medical device developer. The company is mainly engaged in technology research and development and sales in the field of medical devices, providing medical device products to the medical industry.
Highlight Capital VC Fund · Nanjin, Jiangsu, China · 21 investments in the past 12 months
Highlight Capital is an investment firm dedicated to support healthcare companies to generate robust and sustained growth prospect.
Show more
Investment focus
  • Health Care, Medical, Biotechnology
  • Series A, Series B, Seed
  • China, United States, Portugal
Portfolio highlights
  • VelaVigo — VelaVigo is a start-up company engaged in macromolecular biopharmaceuticals.
  • Qianxun Intelligence — Qianxun Intelligence is an intelligent technology developer that offers software development, intelligent robot research and development, AI hardware sales, AI application software development, information system integration services, and Internet sales.
  • E-nitiate Biopharmaceuticals — E-nitiate Biopharmaceuticals is committed to the development of innovative drugs for autoimmune diseases, through independent research and development, and strategic collaborations, to address unmet medical needs and to improve the quality of human life.
Dalton Venture VC Fund · Shanghai, Shanghai, China · 6 investments in the past 12 months
Dalton Venture is a fund management company that specializes in early stage investment and industrial mergers and acquisitions in the field of big health.
Show more
Investment focus
  • Health Care, Medical, Medical Device
  • Seed, Series A, Series B
  • India, China, Canada
Portfolio highlights
  • Astribot — Astribot is a developer of consumer humanoid robots and integrated bionic robots.
  • Yuantian Bio — Yuantian Bio is a biotechnology company specializing in enzymatic regeneration and commercial plastic PET applications. They have achieved low-cost fermentation preparation of over 10 enzyme preparations and large-scale biochemical product preparation.
  • Yuetong Eye Clinic — Yuetong Eye Clinic is a medical institution that provides myopia surgery for adults and myopia prevention and control for adolescents. It is a medical institution focusing on adult myopia surgery and adolescent myopia prevention and control.
Sherpa Healthcare Partners VC Fund · Beijing, Beijing, China · 7 investments in the past 12 months
Sherpa Venture Capital is an investment firm that focuses on the investment and cultivation of the Pharmaceutical and Biotech industry. It also specializes in the investment and management of sector leaders and innovators within the Pharma, GeneTech, MedTech, Medical services, and various sub-sectors, where they have established robust portfoliosources, lasting value-adding cooperations and relationships, as well as mature all-cycle services with key resources. It was founded in 2018 and is headquartered in Beijing, China.
Show more
Investment focus
  • Biotechnology, Health Care, Medical
  • Series A, Series B, Series C
  • China, United States, Kenya
Portfolio highlights
  • AusperBio — AusperBio is a Phase II clinical-stage biopharmaceutical company dedicated to transforming hepatitis B treatment for a cure and advancing oligonucleotide therapeutics. Leveraging their innovative and proprietary Med-Oligo™ ASO platform with effective targeted delivery technologies, AusperBio strives to unleash the power of ASO therapeutics to treata wide range of diseases, including viral infections, metabolic conditions, genetic disorders, and immune diseases.
  • PAQ Therapeutics — PAQ Therapeutics is developing KRAS degraders for deadly cancers without good treatment options.
  • Archimedes Vascular — Archimedes Vascular operates as a medical device company, that treat patients with severe hypertension.
Goldport Capital VC Fund · Shenzhen, Guangdong, China · 8 investments in the past 12 months
Goldport Capital is a Shenzhen-based asset management company.
Show more
Investment focus
  • Manufacturing, Medical, Semiconductor
  • Series A, Seed, Angel
  • China
Portfolio highlights
  • Yurucheng — Yurucheng is a brand of oral materials, specializing in the R&D, production, sales and service of medical oral materials and oral equipment.
  • Zinc Core Titanium — Zinc Core Titanium makes special materials that light up and tiny screens for displays.
  • Rongxin New Materials — Rongxin New Materials is a developer specializing in graphene material science and technology, with a commitment to the research and development of new materials technology and engineering applications. The company focuses on graphene-based heating films and graphene-integrated thermal products that are designed to provide efficient and uniformheating solutions for both consumer and industrial sectors.
BioTrack Capital VC Fund · Shanghai, Shanghai, China · 8 investments in the past 12 months
BioTrack Capital is a China-based investment firm.
Show more
Investment focus
  • Health Care, Biotechnology, Medical
  • Series A, Series B, Seed
  • China, United States, Singapore
Portfolio highlights
  • Spurious — Sipurui is a pharmaceutical company specializing in the development of small molecule anti-tumor drugs, with a particular emphasis on iterative innovation to enhance the efficacy and selectivity of cancer therapies.
  • Cavan Auto — Cavan Auto specializes in the production of electric vehicles and hydrogen fuel cell-powered new energy.
  • Minghui Pharmaceutical — Minghui Pharmaceutical is a biopharmaceutical business that specializes in immunology and oncology medicines for unmet needs.
Taiyu Investment VC Fund · 3 investments in the past 12 months
Taiyu Investment is an investment firm.
Show more
Investment focus
  • Medical, Medical Device, Biotechnology
  • Series A, Angel, Seed
  • China
Portfolio highlights
  • NeuroPlus — NeuroPlus is a developer of bioelectric sensing technologies, with an emphasis on new applications such as precise EEG measurement, smart wearables, and mobile medical care.
  • Yili Pharmaceutical — Yili Pharmaceutical is a pharmaceutical R&D company that mainly engages in biochemical product technology R&D, medical research and experimental development, engineering and technology research and experimental development, and software development.
  • Bochuang Biotechnology — Bochuang Biotechnology is a cutting-edge medical repair product developer that specializes in the controllable electrochemical assembly of biomacromolecules. Bochuang Biotechnology is creating a line of high-end biological tissue functional membranes and derived medical device solutions.
Lenovo Capital and Incubator Group (LCIG) VC Fund · Beijing, Beijing, China · 21 investments in the past 12 months
Lenovo Capital and Incubator Group is an accelerator and venture capital firm.
Show more
Investment focus
  • Manufacturing, Artificial Intelligence, Software
  • Series A, Series B, Seed
  • China, Hong Kong, United States
Portfolio highlights
  • DexForce — DexForce offers an AI-enabled robot with integrated 3D vision cameras, and software and hardware solutions for manufacturing robots.
  • Zhiran Medical — Zhiran Medical is a medical technology company specializing in the precise detection and treatment of neurological disorders using high-throughput, flexible brain-computer interface technology.
  • West Lake Yanshan Technology — West Lake Yanshan Technology is a micro-LED company that focuses on the manufacturing and production of full-color display chips.
Shenzhen Capital Group VC Fund · Shenzhen, Guangdong, China · 46 investments in the past 12 months
Shenzhen Capital Group Co., Ltd (“SCGC”) is a limited venture capital company established by the Shenzhen Government in 1999. Since its establishment, SCGC has focused on cultivating national industries, shaping national brands, promoting economic transformation, and emerging industries developing. SCGC has registered capital of 5.42 billion RMB,and a total AUM of 338.99 billion RMB. SCGC primarily invests in SMEs, innovative high-tech enterprises, enterprises in emerging industries, and enterprises in start-up period, growth period and in transformation, covering industries supported by national policies, including IT, internet, new media, biopharma, new energy, environmental protection, chemical engineering, new material, high-end equipment manufacturing, consumption goods, modern service, etc. By the end of April 2019, SCGC ranked the first based on the number of portfolio companies and the number of listed portfolio companies: 994 portfolio companies, investments totaling 43.9 billion RMB, 145 of which have been listed in 16 capital markets worldwide.
Show more
Investment focus
  • Manufacturing, Health Care, Information Technology
  • Series A, Series B, Series C
  • China, United States, Japan
Portfolio highlights
  • AI² Robotics — AI² Robotics is an embodied intelligent robot company that offers research and development of general intelligent embodied terminals.
  • Jingji Communications — Jingji Communications is the leading developer of advanced aerospace and defense communications technology, specializing in the design, development, and deployment of high-performance systems that support mission-critical operations. With a strong focus on innovation, security, and reliability, Jingji Communications provides cutting-edge solutionsfor secure satellite communication, tactical radio networks, data transmission, and real-time situational awareness.
  • Shouxing Technology — AheadForm is pioneering the development of realistic humanoid robots designed to revolutionize human-robot interaction. Our current focus is on creating sophisticated humanoid robot heads that can express emotions, perceive their environment, and interact seamlessly with humans. By combining cutting-edge AI and advanced robotics, we aim to bring life to machines and transform the way humans engage with technology.
Cenova VC Fund · Shanghai, Shanghai, China · 2 investments in the past 12 months
Cenova Capital is one of the earliest healthcare dedicated funds in China founded in 2010 by Dr Jun WU and is one of the earliest investors in private healthcare services and digital health, with helps to facilitate the transformation of healthcare in China from an exclusively state-owned system to a more efficient, market-oriented system. CenovaCapital is healthcare funds dedicated to early and growth-stage investments in the life sciences and healthcare sector in China. Since inception in 2010, Cenova now has five funds under management with investments in over 50 companies in healthcare services, pharmaceuticals, medical devices and digital heath. Cenova's investors are mainly large domestic and international institutional investors including Asian sovereign wealth funds, government institutions, insurance and financial institutions and multinational companies.
Show more
Investment focus
  • Health Care, Medical, Biotechnology
  • Series B, Series A, Series C
  • China, Singapore, United States
Portfolio highlights
  • Weimai — Weimai is a developer of a health application platform intended to provide medical and health services. The company's health application platform offers an Internet-based appointment, distribution, maternal and child disease management, grading diagnosis and treatment as well as remote diagnosis, and medical records management, providing userswith a family doctor application in every home.
  • Haofeng Medtech — Haofeng Medtech is a CDMO service provider of interventional medical devices.
  • Agile Medical — Agile Medical, a surgical robot company, focuses on research, development, and industrialization of intelligent surgical products. Agile Medical's technology innovation platform covers mechanics, electronics, optics, computing, and software.
CD Capital VC Fund · Shanghai, Shanghai, China
CD Capital is a venture capital firm specialized in life sciences and medical technology. They are currently managing both RMB and USD funds with total size of $600M. CD Capital is operated by a professional team with diversified and profound industry backgrounds. They have made over 40 investments with high growth potential and earned a reputationas a premier venture capital firm with main focus on China healthcare industry. With broad network around China and the world, they have been able to seize the global trend, capture investment opportunities as well as help to define the future for China healthcare industry. Ultimately, they strive to grow best-in-class companies and deliver solid financial return to their investors.
Show more
Investment focus
  • Health Care, Biotechnology, Medical Device
  • Series A, Series B, Seed
  • China, United States
Portfolio highlights
  • Healingovation — Healingovation is a med-tech company that specializes in the development and manufacturing of surgical robots, intelligent diagnosis and treatment equipment.
  • Greenon Biotech — Greenon Biotech specializes in the research, development, production, and promotion of alternative antibiotic preparations for animals, which primarily include bacteriophages, probiotics, plant extracts, novel acid preparations, high-efficiency disinfectants, and so on.
  • Qihe Biotech — Qihe Biotech develops novel genome editing technologies with an emphasis on making them autonomous and programmable.
Hillhouse Investment VC Fund · Changyang, Beijing, China · 8 investments in the past 12 months
Founded in 2005, Hillhouse is a leading global investment management firm, active across public equity, private equity, real estate and private credit. The firm invests over a long-term horizon and partners with exceptional entrepreneurs to deliver sustainable value creation for quality companies.Hillhouse is a full life-cycle private equityfirm, investing for the long term across opportunities in the healthcare, business services, consumer, and industrials sectors. The firm manages capital on behalf of global institutions such as non-profit foundations, endowments, and pensions.
Show more
Investment focus
  • Biotechnology, Health Care, Software
  • Series B, Series A, Series C
  • China, United States, Singapore
Portfolio highlights
  • Sainte — Sainte is a company which provides professional nutritional solutions for babies with different nutritional needs
  • Vita Dynamics — Vita Dynamics involves learning through real-world interactions by developing robots that can physically engage with their environment, they can adapt more naturally and efficiently.
  • Horizon Continental Technology — Horizon Continental Technology is a joint venture between Continental Group and Horizon Robotics
Oriza Seed Capital (Oriza Yuandian) VC Fund · Suzhou, Jiangsu, China · 14 investments in the past 12 months
Oriza Seed Venture Capital, located in Suzhou Industrial Park, is held by Suzhou Oriza Holdings Ltd. Oriza Seed is a market-oriented investment platform. It looks for investment opportunities among early-stage and growth-stage enterprises in the fields of Healthcare and TMT. Oriza Seed has ample resources and experiences investing in the healthcarefield. By late March 2016, Oriza Seed has invested in more than 50 healthcare companies, including Ascentage Pharma, Innovent Biologics, and SceneRay Corporation.
Show more
Investment focus
  • Manufacturing, Health Care, Biotechnology
  • Series A, Seed, Angel
  • China, United States, Singapore
Portfolio highlights
  • Minova Pharma — Minova Pharma focuses on the development of novel medications in the spiritual and medicinal beauty domains.
  • Scanner Optics Co.,Ltd — Scanner Optics is professional in galvanometer scanners, controllers, software, optics, encoders and customized galvanometer systems. Our galvo scanner products have been applied in many industries: laser marking, laser cutting, laser welding, laser scanning, 3D printing and so on. Contact Scanner Optics now!
  • Xili Optoelectronics — Xili Optoelectronics is a pioneering company focused on the development of advanced, future-oriented optical engine system integrated chips (OE-SICs) that deliver high bandwidth and low energy consumption.
Huagai Capital VC Fund · Beijing, Beijing, China · 5 investments in the past 12 months
Huagai Capital is a private equity investment firm that invests in start-up or growth companies in the areas of healthcare, TMT, and culture.
Show more
Investment focus
  • Health Care, Biotechnology, Medical
  • Series A, Series B, Seed
  • China, United States, Germany
Portfolio highlights
  • ViGeneron — ViGeneron is dedicated to developing innovative gene therapies to treat ophthalmic diseases with high unmet medical need, as well as partnering with leading biopharmaceutical players in other disease areas. The company’s pipeline is built on two proprietary adeno-associated virus (AAV) technology platforms. The first, vgAAV gene therapy vectorplatform, allows superior transduction efficiency and intravitreal, less invasive treatment administration. The second, REVeRT vector platform, targets diseases caused by mutations in large genes. Privately-owned ViGeneron was founded in 2017 by a seasoned team with in-depth experience in AAV vector technology and clinical ophthalmic gene therapy programs and is located in Munich, Germany.
  • Moyang Biotechnology — Moyang Biotechnology specializes in the development and consulting services of medical biomaterials for beauty sector.
  • Index Technology — Index Technology is a company that specializes in applying artificial intelligence technology to electronic design and production. Index Technology uses generative AI technology to optimize the traditional R&D process for electrical devices, and it offers automated generation services ranging from product requirements to PCBA manufacturingdesigns and supporting embedded programs.
Kaitai Capital VC Fund · Hangzhou, Zhejiang, China
KAITAI CAPITAL, founded in 2009, is a professional investment management organization that mainly engaged in innovative investment, industrial investment, and wealth management business. Fields of investment include biopharma, healthcare services, agriculture tech, consumer business, digital technology and etc.
Show more
Investment focus
  • Biotechnology, Health Care, Pharmaceutical
  • Series A, Angel, Series B
  • China, United States
Portfolio highlights
  • Xinyue — Yuejing Network Technology Co., Ltd. is a digital video assistant platform that cuts in the communication and review links in the video production stream, helping to achieve multi-platform preview of video demos in video production and convenient review comments and video storage. sort out. With the subsequent connection of external hardware, theuser can realize the real-time synchronization of the video data captured in the camera to the new cloud server, and later can synchronize production and storage sharing through the new reading.
  • Sheng Sheng Biology — Sheng Sheng Biology is a biotechnology company that provides medical research and experimental development services.
  • TechnoDerma Medicines — TechnoDerma Medicines focuses on the research and development of innovative skin drugs for external use.
Long Hill Capital VC Fund · Shanghai, Shanghai, China
Long Hill Capital is a next generation thesis-driven venture capital firm. We invest in technology-enabled healthcare and consumer services companies which seek to massively improve health and quality of life for every Chinese.Since 2005 the founding team of Long Hill Capital have led the China investing practice for New Enterprise Associates(NEA), a global investment firm with over $17 billion in committed capital. They are joined by an experienced team of investment and operations professionals from such firms as Matrix Partners China and Morningside VC. Together the Long Hill Capital team have over 30 years of China venture capital experience and over 15 years of senior operating experience at some of China’s most successful technology and healthcare companies including Alibaba, Huawei and Ping’an Good Doctor.Over the course of their venture capital careers, the Long Hill Capital team have invested in such industry leading companies as CITIC Pharmaceutical, WeDoctor, Hygeia Medical Services, GST Clinics, LineKong, LianLian Pay, Ele.Me, TheBeastShop and more.
Show more
Investment focus
  • Medical, Health Care, Medical Device
  • Series A, Series B, Angel
  • China, United States
Portfolio highlights
  • Filan Air — Filan Air develops technology for improving air quality, such as air treatment for medical laboratories.
  • Aibo Medical Robot — Aibo Medical Robot was established in Shenzhen in June 2020, focusing on the vascular interventional surgery robot market. It is reported that behind this "new" company is the accumulation of years of scientific research and technology - that is , the nearly 30 years of research and development accumulation of the founding team.
  • Oushisheng Technology — Oushisheng Technology is a national high-tech company that provides complete solutions for micro-reaction flow chemistry to people all over the world.
Gaorong Capital VC Fund · Wangjing, Beijing, China · 11 investments in the past 12 months
Gaorong Capital is a venture capital firm that focuses on early and growth stage investments in TMT, including AI and frontier technologies.
Show more
Investment focus
  • Information Technology, Artificial Intelligence, E-Commerce
  • Series A, Series B, Series C
  • China, United States, Hong Kong
Portfolio highlights
  • Flexiv — Flexiv is a deep-tech company that is committed to developing and manufacturing general-purpose adaptive robots that redefine intelligent automation. Combining advanced robotics and artificial intelligence with human-centered design, Flexiv's robots empower businesses to flexibly automate complex tasks with intuitive and easy-to-use interfaces.
  • Nova Fusion — Nova Fusion is an innovative company that provides commercialization of small modular nuclear fusion reactors.
  • Tongxin Medical Equipment — Tongxin makes magnetically-suspended artificial blood pumps which are designed to replace the human heart. They are undergoing clinical trials in China after being fast-tracked through the approval process by the National Medical Products Administration, state-run Xinhua News Agency
Trustbridge Partners VC Fund · Boston, Massachusetts, United States
Trustbridge Partners is a mission-driven growth equity firm founded in 2006 with approximately $8 billion under management.
Show more
Investment focus
  • Health Care, Education, Medical
  • Series A, Series B, Series C
  • China, United States, United Kingdom
Portfolio highlights
  • Cherre — Connect all your real estate data and make it available to the entire organization for better investment, management, and underwriting decisions.
  • Metafoodx — Metafoodx is on a mission to solve the challenge of food waste. We believe that it is one of the most critical factors for achieving global sustainability.
  • Hope Medicine — Hope Medicine is committed to researching, developing and commercializing the first innovative drugs aimed at improving the quality of life for a wide range of popular male and female diseases.
Sunland Fund VC Fund · Shanghai, Shanghai, China
Shanlan Capital is a professional fund focused on early and growing health care industry investments with offices in Shanghai and Beijing, focusing on biomedical and medical devices (in vitro diagnostics and gene technology, minimally invasive interventions, implantable devices, minimally invasive High-growth segments such as surgical instrumentsand medical robots, and medical services. It has invested in 15 medical star companies such as Guoke Hengtai, Ricky Surgery, Jingyi Medical, Haipulos, Langhe Medical, etc. The core team of Shanlan Capital is the founder of the medical industry listed company, professional financial and strategic investment. Composition of people, in strategy formulation, talent introduction, technology research and development, market camp..
Show more
Investment focus
  • Health Care, Medical, Medical Device
  • Series A, Series B, Seed
  • China
Portfolio highlights
  • JH Cispoly — JH Cispoly develops diagnostic technology and equipment for gynecological tumors.
  • Better Medtech — Better Medtech is a provider of innovative solutions for urinary and pelvic floor health. Its primary business is the research and development, production, sales, and related services of specialized medical devices, with a focus on creating comprehensive and precise revolutionary products in markets such as benign prostatic hyperplasia, urinaryincontinence, stones, and novel tumour therapies.
  • Medtech Technology — Medtech Technology is a firm that develops innovative ophthalmic medical devices.It has developed its own artificial lens production and research technology platform, as well as a technological barrier to high-end artificial lens manufacture.
BIOCHING CAPITAL VC Fund · Longgang, Guangdong, China · 3 investments in the past 12 months
BIOCHING CAPITAL is an investment management firm.
Show more
Investment focus
  • Medical Device, Biotechnology, Medical
  • Angel, Series A, Seed
  • China
Portfolio highlights
  • Taose Tuantuan — Taose Tuantua is a sex toy company that primarily offers TAOSETT sex toy academy and exquisite sex toy community store services.
  • Weimai Medical — Weimai Medical is an all-inclusive resource for minimally invasive and non-invasive energy medicine solutions.
  • Qinglan Jichuang — Qinglan Jichuang is a domestic high-performance intelligent endoscope innovative enterprise.
LYFE Capital VC Fund · Shanghai, Shanghai, China · 2 investments in the past 12 months
LYFE Capital is a pure play healthcare focused investment firm. We believe that “Healthcare has no boundaries”, and that every new choice we made has the potential to advance healthcare and solve the unmet needs for everyone. LYFE Capital operates 5 global offices including our US headquarters in Menlo Park, California, our Asia headquarters inSingapore, as well as locations in Seoul, Tokyo and Shanghai. We leverage our expertise and global resources to invest in and create value for healthcare companies across the globe. LYFE Capital’s investments span medical devices, therapeutics, diagnostics, and emerging sectors across North America and Asia.
Show more
Investment focus
  • Biotechnology, Health Care, Medical
  • Series B, Series A, Series C
  • China, United States, France
Portfolio highlights
  • CytoTronics — CytoTronics is designing and developing cell culture plates with embedded high-density electronic systems.
  • Verdiva Bio — Verdiva Bio is committed to developing next-generation therapies to help people living with obesity, cardiometabolic disorders, and related complications achieve better outcomes via more patient-friendly therapeutic options.
  • Neurona Therapeutics — Neurona Therapeutics is a pre-clinical stage biotechnology company that was founded by four neuroscientists and stem cell pioneers at The University of California, San Francisco. They are focused on the discovery and development of cell-based therapies to treat intractable neurological disease. Its initial aim is to generate therapeuticcompositions of a specific type of nerve cell (or neuron) for targeted delivery into the injured nervous system. Based on nearly two decades of research, they believe that particular subpopulations of neurons have the unique ability to integrate and repair dysregulated neural circuits. Its talented team of scientists, scientific advisors, and board directors is working to accelerate breakthrough treatments for patients with significant unmet medical needs.
Tiantu Capital VC Fund · Shenzhen, Guangdong, China
Tiantu Capital is a venture capital association.
Show more
Investment focus
  • Food and Beverage, E-Commerce, Health Care
  • Series A, Series B, Series C
  • China, United States, Japan
Portfolio highlights
  • Recorna Bio — Recorna Bio specializes in biotechnology, focusing on RNA editing and genome modifications through advanced research and development. They aim to innovate in genetic engineering, contributing to advancements in biomedicine and agriculture with cutting-edge technologies and scientific expertise.
  • Leman Biotech — Leman Biotech is a biotech company that is engaged in development of cancer immunotherapies.
  • Xellar Biosystems — Xellar Biosystems is a wet artificial intelligence biotechnology company that provides analysis of drug testing and treatment.
Pan-Lin Capital VC Fund · Shanghai, Shanghai, China · 8 investments in the past 12 months
Panlin Capital, following the investment theme of ‘consumption upgrade driven by technology innovation’, targets the start-ups which are specialized in biotechnology and data intelligence sectors.As a venture capital corporation, Panlin Capital has became professional as well as influential in the biotechnology and data intelligence sectors.Identify the entrepreneurs among scientists.Enable the innovators among entrepreneurs。
Show more
Investment focus
  • Health Care, Biotechnology, Medical
  • Series A, Seed, Series B
  • China, United States, Canada
Portfolio highlights
  • Libo Biotech — Libo Biotech is a cutting-edge biotechnology company dedicated to the discovery and development of innovative small molecule therapeutics that specifically target RNA.
  • Huarui Shuxin — Huarui Shuxin develops high-performance and high-reliability domestic RAID control cards in the field of core storage hardware.
  • Suzhou Ribo Life Science — Established in 2007, Suzhou Ribo Life Science Co. Ltd. is devoted to the advanced oligonucleotide therapeutics in China including siRNA, antisense and aptamer drugs based on proprietary intellectual properties.
Taiyu Investment VC Fund · Beijing, Beijing, China
Taiyu Investment is an investment firm.
Show more
Investment focus
  • Medical, Health Care, Biotechnology
  • Series A, Seed, Angel
  • China
Portfolio highlights
  • Immorna — Immorna specializes in the production of RNA-based therapeutics.
  • ChomiX Biotech — ChomiX Biotech will always manage the company's development with a realistic, disciplined, and excellence-driven scientific research mindset. In addition, the company will use cutting-edge technology to solve problems for clients and generate revenue. We can only see the stars if we stay grounded. ChomiX will continue to research and developits own core technology in order to continually maintain its top rank on the track and steer the development of the industry.
  • Weixin Medical — Weixin Medical is an innovative medical device platform for women's health.
Haibang Capital VC Fund · Hangzhou, Zhejiang, China
Zhejiang Haibang Investment Management Co., Ltd. (also referred as "Haibang Capital") is an investment company focusing on venture capital and private equity. It was established in 2011 in Hangzhou. It was founded by Naxin Yao, the CEO of Focused Photonics, Inc (300203), a number of returnee entrepreneurs and experienced investmentprofessionals. In 2011, Haibang Capital launched its first Haibang Fund (formerly called “Haibang Talent Fund”) which was the first venture capital in China helping new returnees to start their own businesses. It is also a fund connect capital and "Thousand Talent Program" in Zhejiang Province. Haibang Capital keeps working on helping enterprises grow rapidly and build leading edge in their industry. In addition to providing capitals, Haibang Capital provides its investee companies with personalized value-added services, helping create both good economic and social benefits.
Show more
Investment focus
  • Health Care, Biotechnology, Medical Device
  • Series A, Angel, Series B
  • China
Portfolio highlights
  • MetaLenX — MetaLenX is a technology-based enterprise focusing on the design, manufacture and application of superlenses.
  • Huashen Ruili — Huashen Ruili is a manufacturer and retailer of auto parts. It focuses on the advancement of drive motor systems' dry brake-by-wire technology.
  • Jianxin Jiaren — Jianxin Jiaren is a manufacturing business that creates and markets chemical products and raw materials. It uses a chemical recycling system, discarded waste textiles, and uses chemical decomposition technology to reduce waste polyester materials into small chemical molecules. It reduces dependence on petroleum resources and waste generation.
Sunz Fund VC Fund · Changsha, Jiangsu, China
Sunz Fund is a venture capital firm that focuses on investments in life science, medical health and resources environment sectors.
Show more
Investment focus
  • Medical, Health Care, Biotechnology
  • Series A, Seed, Series B
  • China
Portfolio highlights
  • Errui Xinyue — Errui Xinyue is a developer of early diagnosis technology and products for neurodegenerative diseases. It focuses on the research and use of exosome-related technologies and is committed to progressing the advancement of life and health through technological innovation.
  • Maybio Matrix — Meibai bio focuses on the R&D, production & sales of biological scaffold material for maxillofacial tissue regeneration for medical and medical plastic and cosmetic clinical needs.
  • Changsha Morning Shine — Changsha Morning Shine is an innovative pharmaceutical company that specializes in R&D outsourcing, biomedicine, chemical drugs, and biotechnology services.
Insight Capital VC Fund · Beijing, Beijing, China
Insight Capital is a venture capital firm focused on early-stage investment.
Show more
Investment focus
  • Health Care, Medical, Biotechnology
  • Series A, Series B, Series C
  • China
Portfolio highlights
  • Sieran Medical — Sieran Medical is a medical device company that provides precise and intelligent minimally invasive surgical treatment solutions for ophthalmology.
  • Amity Solutions — Enterprise Chatbots, AI-based generative Chatbots, pre-built social features for apps and websites, and building blocks for employee experiences.
  • Iongen Therepeutics — Iongen Therepeutics is an innovative drug research and development company focusing on pain treatment.
Oriental Fortune Capital VC Fund · Shenzhen, Guangdong, China · 8 investments in the past 12 months
Shenzhen Oriental Fortune Capital Co Ltd. is a venture capital firm specializing investment in early venture, mid venture, late venture, emerging growth, Pre-IPO, mature, growth capital stage, mezzanine and new third board investments. The firm typically invests in financial services, telecommunication, new energy, consumer goods, medical treatmentand healthcare, life sciences, internet plus healthy lifestyle industry, logistics, energy technology, information technology, mobile innovation, media, movies and television, culture, pharmaceutical, biological medicine, renewable energy, retail, environmental protection business, consumption, new materials, new agriculture, advanced manufacturing, equipment manufacturing, culture, entertainment, and services. It seeks to invest in China focusing on Shenzhen, Shanghai, Beijing, Xi’an, and Wuhu. The firm also invests in Pearl River Delta region, Yangtze River Delta region, and Circum-Bohai-Sea region. For Pearl River Delta, it covers Guangzhou, Shenzhen, Foshan, Dongguan, Zhongshan, Zhuhai, Huizhou, Jiangmen, and Zhaoqing cities in China. For Yangtze River Delta, the firm covers Shanghai, Nanjing, Wuxi, Changzhou, Suzhou, Nantong, Yancheng, Yangzhou, Zhenjiang, Taizhou, Hangzhou, Ningbo, Jiaxing, Huzhou, Shaoxing, Jinhua, Zhoushan, Taizhou, Hefei, Wuhu, Ma’anshan, Tongling, Anqing, Chuzhou, Chizhou, and Xuancheng cities in China. For the Circum-Bohai-Sea region, it covers Beijing, Tianjin, Shenyang, Dalian, Qingdao, Dandong, Yingkou, Panjin, Fuxin, Huludao, Chaoyang, Shijiazhuang, Baoding, Tangshan, Qinhuangdao, Cangzhou, Langfang, Chengde, Zhangjiakou, Handan, Xingtai, Dongying, Yantai, Weifang, Weihai, Rizhao, and Binzhou cities in China. The firm prefers to invest 20% of its portfolio to early stage, 40% to expansion stage, and 40% to Pre-IPO stage. Shenzhen Oriental Fortune Capital Co Ltd. was formed in November 2007 and is based in Shenzhen, China with offices in Shanghai, China; Beijing, China; and Wuhu, China.
Show more
Investment focus
  • Manufacturing, Software, Information Technology
  • Series A, Series B, Seed
  • China, United States
Portfolio highlights
  • X-ORIGIN — X-ORIGIN is an intelligent robot developer focused on creating AI companion robots for a variety of applications. Its technical architecture emphasizes the integration of terminal control and massive language models, with the goal of providing a personalized interactive experience and creating more consumer-grade products based on self-developed AImodels.
  • Xuanchuang Robotics — Xuanchuang Robotics is a leading provider of cutting-edge intelligent operations and maintenance solutions, specializing in advanced robotics technologies.
  • West Lake Intelligent Vision — West Lake Intelligent Vision is a developer of artificial intelligence and computational imaging fusion technology.
Co-Stone Venture Capital VC Fund · Shenzhen, Guangdong, China · 9 investments in the past 12 months
Co-Stone Capital is a leading China based private equity firm headquartered in Shenzhen. Founded more than 16 years ago, Co-Stone is one of China's earliest private equity institutions. Co-Stone Capital focuses primarily on China domestic growth stage and Pre-IPO opportunities, basing investment decisions on a deep understanding of the Chineseeconomy and company specific growth patterns. We put heavy emphasis on stable growth in key industries, including TMT, healthcare, consumer products & services and advanced manufacturing. Co-Stone Capital approaches the capital markets with broad vision but detailed focus, maintaining an emphasis on value-adding services. We have invested in over 100 companies, the majority of which were lead investments and have successfully exited from 40 companies through IPO, M&A or reverse mergers. Our exit rates and ROI are far in excess of industry averages. Co-Stone Capital has assets under management in excess of 40 billion RMB, across funds covering private equity, venture capital, PIPE, M&A and fixed income. Co-Stone has a diverse capital base, with LPs ranging across large insurance groups, government guided funds, funds of funds, large corporations, entrepreneurs and high net worth individuals. Co-Stone Capital has received numerous accolades from Forbes, Zero2IPO,ChinaVenture and other industry publications which consistently rank us in the top 10. Co-Stone Capital is headquartered in Shenzhen, with offices in Beijing,Shanghai and Hefei.
Show more
Investment focus
  • Manufacturing, Semiconductor, Health Care
  • Series B, Series A, Series C
  • China, United States, Hong Kong
Portfolio highlights
  • PaXini Tech — All Scenario Application—Haptic Digitization and Tactile Technology
  • Ganwei Technology — Wuhan Ganwei Technology is a manufacturer of gas instruments and meters. Its main products include short optical path gas pools, online ultraviolet gas analyzers, gas sensors, oil and gas infrared spectroscopy logging tools, and high-precision automatic gas distribution instruments, etc., which are mainly used in environmental protection,Petrochemical and other fields.
  • Changzhou Fuxing Mechanical and Electrical Co. — Changzhou Fuxing Mechanical and Electrical Co. manufactures servo, brushless DC, and hybrid stepper motors.
Shunwei Capital VC Fund · Beijing, Beijing, China · 21 investments in the past 12 months
Shunwei Capital is a venture capital fund that focuses on early to mid-stage investments in local internet industry. It specializes in incubation, startups, early to mid-stage, and growth capital investments. It seeks to invest in the technology, media, telecommunications, high technology, new media, games, internet finance, and rural area internetsectors. Their investors include sovereign wealth funds, fund of funds, university endowment funds, and family offices.
Show more
Investment focus
  • Manufacturing, Software, Internet
  • Series A, Series B, Series C
  • China, India, United States
Portfolio highlights
  • Wala English — Wala English is a provider of comprehensive full-process AI contextual learning services, leveraging artificial intelligence to deliver personalized, immersive language learning experiences that adapt to each learner’s needs, context, and progress throughout their educational journey.
  • Xunlu Innovation — Xunlu Innovation is a cutting-edge bicycle manufacturer based in Shenzhen, China, specializing in intelligent electric cargo bikes designed to meet modern urban mobility needs.
  • Shouxing Technology — AheadForm is pioneering the development of realistic humanoid robots designed to revolutionize human-robot interaction. Our current focus is on creating sophisticated humanoid robot heads that can express emotions, perceive their environment, and interact seamlessly with humans. By combining cutting-edge AI and advanced robotics, we aim to bring life to machines and transform the way humans engage with technology.
Investors by industry
Investors by country
Investors in China by industry